Iodide

Iodide

SCHEMBL3927328

I.I.I.I.I.[NaH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL21530823 1.00
Iodide SCHEMBL2526595 1.00
Iodide SCHEMBL4656337 1.00
Iodide SCHEMBL11780450 1.00 CA4 (0.50)
Iodide SCHEMBL9131250 1.00
Iodide SCHEMBL60665 1.00
Iodide SCHEMBL7922251 1.00
Iodide SCHEMBL9632840 1.00
Iodide SCHEMBL2872084 0.82
Iodide SCHEMBL21814229 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035021-A2 TREATMENT OF MOUTH AND URINARY TRACT INFECTIONS Frio Technologies, Inc. (US) 2009-03-18 EP claimed
WO-2008005059-A2 TREATMENT OF MOUTH AND URINARY TRACT INFECTIONS FRIO TECHNOLOGIES, INC. (US) 2008-01-10 WO claimed
US-12002631-B2 Electrodeposited dielectric for a solid electrolytic capacitor KYOCERA AVX Components Corporation (US) 2024-06-04 US disclosed
US-20230118528-A1 Electrodeposited Dielectric for a Solid Electrolytic Capacitor KYOCERA AVX Components Corporation 2023-04-20 US disclosed
US-8206752-B2 Rejuvenation of reverse osmosis membrane BIOMEDICAL DEVELOPMENT CORPORATION (US) 2012-06-26 US disclosed
EP-2035021-A2 TREATMENT OF MOUTH AND URINARY TRACT INFECTIONS Frio Technologies, Inc. (US) 2009-03-18 EP disclosed
WO-2008005059-A2 TREATMENT OF MOUTH AND URINARY TRACT INFECTIONS FRIO TECHNOLOGIES, INC. (US) 2008-01-10 WO disclosed
US-20070289924-A1 Rejuvenation of reverse osmosis membrane BIOMEDICAL DEVELOPMENT CORPORATION 2007-12-20 US disclosed